Covered recipient · General Payments record
KEVIN TIN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2025 · Entire year
$52,991.33
164 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2025 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,845.50 | 14 |
| Food and Beverage | $4,831.36 | 145 |
| Consulting Fee | $2,472.50 | 2 |
| Travel and Lodging | $841.97 | 3 |
By paying entity
PY2025 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Madrigal Pharmaceuticals | $30,963.39 | 47 |
| Phathom Pharmaceuticals, Inc. | $7,965.83 | 14 |
| ABBVIE INC. | $6,556.72 | 31 |
| Gilead Sciences, Inc. | $6,194.35 | 25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $250.92 | 13 |
| Ardelyx, Inc. | $196.54 | 8 |
| Abbott Laboratories | $187.04 | 1 |
| Boston Scientific Corporation | $140.58 | 1 |
| QOL Medical, LLC | $125.93 | 5 |
| Janssen Biotech, Inc. | $116.26 | 5 |
| VIVUS LLC | $97.50 | 5 |
| PFIZER INC. | $50.20 | 2 |
| Novo Nordisk Inc | $48.74 | 2 |
| Aimmune Therapeutics, Inc. | $34.62 | 2 |
| Exact Sciences Corporation | $22.28 | 1 |
| Ipsen Biopharmaceuticals, Inc | $20.45 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $19.98 | 1 |
Page 2 of 4; records 51–100 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
KEVIN TIN
NPI 1174812044 · CMS profile ID 1382257
Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology
BROOKLYN, NY
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 4; records 51–100 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1174812044?year=2025&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- KEVIN TIN, NPI 1174812044, CMS profile ID 1382257. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174812044?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- APA 7
- IndustryPayments. (2026). KEVIN TIN, NPI 1174812044, CMS profile ID 1382257. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174812044?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- Bluebook
- KEVIN TIN, NPI 1174812044, CMS profile ID 1382257, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1174812044?year=2025&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30
164 matching records · $52,991.33 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 164.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.70 | 09/03/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1231941653 | CMS |
| Gilead Sciences, Inc. | $29.16 | 08/29/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234443435 | CMS |
| Madrigal Pharmaceuticals | $12.00 | 08/28/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316710 | CMS |
| Madrigal Pharmaceuticals | $128.88 | 08/26/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316706 | CMS |
| Madrigal Pharmaceuticals | $3,548.00 | 08/26/2025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316708 | CMS |
| Gilead Sciences, Inc. | $25.02 | 08/22/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234474138 | CMS |
| Ardelyx, Inc. | $29.39 | 08/20/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1247888389 | CMS |
| ABBVIE INC. | $7.80 | 08/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1204534035 | CMS |
| Madrigal Pharmaceuticals | $9.95 | 08/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316704 | CMS |
| ABBVIE INC. | $14.79 | 08/15/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1204534031 | CMS |
| Madrigal Pharmaceuticals | $122.38 | 08/14/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316700 | CMS |
| Madrigal Pharmaceuticals | $3,548.00 | 08/14/2025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316702 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.59 | 08/14/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1219275352 | CMS |
| ABBVIE INC. | $20.62 | 08/13/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1204534027 | CMS |
| Gilead Sciences, Inc. | $8.79 | 08/11/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234589690 | CMS |
| Gilead Sciences, Inc. | $3.66 | 08/08/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234606157 | CMS |
| Madrigal Pharmaceuticals | $11.43 | 08/07/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316698 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $11.08 | 07/28/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1231941650 | CMS |
| Madrigal Pharmaceuticals | $70.44 | 07/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316690 | CMS |
| Madrigal Pharmaceuticals | $38.03 | 07/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316692 | CMS |
| Madrigal Pharmaceuticals | $94.65 | 07/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316694 | CMS |
| Madrigal Pharmaceuticals | $57.41 | 07/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316696 | CMS |
| Madrigal Pharmaceuticals | $6,127.50 | 07/18/2025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316680 | CMS |
| Madrigal Pharmaceuticals | $301.96 | 07/18/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316682 | CMS |
| Madrigal Pharmaceuticals | $244.08 | 07/18/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316684 | CMS |
| Madrigal Pharmaceuticals | $295.93 | 07/18/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316686 | CMS |
| Madrigal Pharmaceuticals | $196.14 | 07/18/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316688 | CMS |
| Phathom Pharmaceuticals, Inc. | $29.43 | 07/17/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1219275350 | CMS |
| ABBVIE INC. | $28.46 | 07/15/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1204534023 | CMS |
| Madrigal Pharmaceuticals | $9.72 | 07/15/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316678 | CMS |
| Ardelyx, Inc. | $26.67 | 07/14/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1247888387 | CMS |
| Madrigal Pharmaceuticals | $26.92 | 07/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316676 | CMS |
| VIVUS LLC | $19.30 | 07/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1188054498 | CMS |
| Phathom Pharmaceuticals, Inc. | $8.51 | 07/08/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1219275354 | CMS |
| Madrigal Pharmaceuticals | $9.27 | 07/01/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316674 | CMS |
| Gilead Sciences, Inc. | $24.50 | 06/27/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234479508 | CMS |
| Madrigal Pharmaceuticals | $7.84 | 06/24/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316672 | CMS |
| Ardelyx, Inc. | $21.11 | 06/20/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1247888385 | CMS |
| ABBVIE INC. | $17.52 | 06/11/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1204534019 | CMS |
| Gilead Sciences, Inc. | $17.12 | 06/11/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234556797 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.67 | 06/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1231941643 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $25.00 | 06/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1231941646 | CMS |
| Madrigal Pharmaceuticals | $7.68 | 06/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316670 | CMS |
| Aimmune Therapeutics, Inc. | $20.36 | 06/06/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1249690125 | CMS |
| Gilead Sciences, Inc. | $2.88 | 05/28/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234607843 | CMS |
| Madrigal Pharmaceuticals | $16.91 | 05/27/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1248316668 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.40 | 05/27/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1231941640 | CMS |
| Janssen Biotech, Inc. | $27.07 | 05/22/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1175317059 | CMS |
| Gilead Sciences, Inc. | $2,830.00 | 05/21/2025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234356082 | CMS |
| Gilead Sciences, Inc. | $24.43 | 05/20/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234480170 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $175,629.15 | 5 |
| PY2024 | Principal investigator | $25,562.00 | 2 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
5 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $18,587.91 | 10/10/2025 | Non-covered Recipient Entity MEDTRAITS NY LLC | ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE | No dispute reported | 06/30/2026 | 1223286717 |
| Principal investigator 1 | Novartis Pharmaceuticals Corporation | $89.47 | 08/08/2025 | Non-covered Recipient Entity WCG MEDTRIATS NY | A Phase III, Multicenter, Randomized, Placebo Controlled, Double-blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) Versus Placebo, With or Without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patient | No dispute reported | 06/30/2026 | 1190312847 |
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $1,199.22 | 05/02/2025 | Non-covered Recipient Entity MEDTRAITS NY LLC | ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE | No dispute reported | 06/30/2026 | 1223278930 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $88,918.10 | 03/19/2025 | Non-covered Recipient Entity MEDTRAITS NY | A Phase 2 randomized double blind placebo controlled dose regimen range finding study to assess efficacy and safety of subcutaneous tozorakimab in adult participants with uncontrolled asthma on medium to high dose inhaled corticosteroids | No dispute reported | 06/30/2026 | 1185537263 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $66,834.45 | 01/17/2025 | Non-covered Recipient Entity MEDTRAITS NY | A Phase 4 Multicenter Randomized Double blind Parallel Group Placebo controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK) | No dispute reported | 06/30/2026 | 1185537261 |